Views & Analysis How will STPs change the face of the NHS in 2017? What changes will STPs bring and what are the implications for pharma?
Views & Analysis How can pharma help NHS improve mental health services? Sustainability and Transformation Plans present an opportunity for pharma to support research into mental health conditions.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
